• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, January 26, 2024

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from mHealthIntelligence referenced a study published in the January 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey,” concluded that discussing the motivation of patients to use telehealth could help policy makers and administrators to maximize health care access and quality.

An article from Good Men Project referenced an article published in the April 2021 issue of AJMC. The piece, “Enhance Care Continuity Post COVID-19,” argued that the pandemic had created an opportunity to augment continuity to improve patient-centered outcomes and improve spending efficiency.

An article from Biospace referenced an article published on AJMC.com, the website of AJMC. The article, “Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD,” reported gene therapy in the treatment of sickle cell disease could be cost effective if it was priced below the $2 million mark.

Related Videos
Stephanie L. Graff, MD, an expert on breast cancer
Debra Boyer, MD, MHPE, ATSF.
Ioana Preston, MD, a pulmonologist
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.